⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ether SCHEMBL9248674 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL21406 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL6 | 0.85 | — | — | |
| Ether SCHEMBL8160191 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL9248046 | 0.85 | ALDH1A1 (0.47) | — | |
| Ether SCHEMBL9175580 | 0.84 | — | — | |
| Ether SCHEMBL8391342 | 0.80 | — | — | |
| Ether SCHEMBL11883416 | 0.80 | — | — | |
| Ether SCHEMBL2884734 | 0.80 | — | — | |
| Ether SCHEMBL10719709 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117295752-A | Monomers, polymerizable compositions, and polymers derived therefrom | 3M创新有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-115024997-B | Cosmetic composition with skin aging resisting effect | 彭氏(惠州)实业发展有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-114426291-B | ZSM-5 zeolite molecular sieve and synthesis method and application thereof | 中国石油化工股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2006121058-A1 | ORGANOMETALLIC COMPOUND, CATALYST FOR POLYMERIZATION OF POLAR GROUP-CONTAINING NORBORNENE AND PROCESS FOR PRODUCING NORBORNENE POLYMER | FUJIFILM CORPORATION (JP) | 2006-11-16 | — | — | WO | disclosed |
| EP-1201649-B1 | Glucocorticoid receptor modulators | PFIZER PROD INC (US) | 2006-05-31 | — | — | EP | disclosed |
| EP-1201660-B1 | Glucocorticoid receptor modulators | PFIZER PROD INC (US) | 2005-08-31 | — | — | EP | disclosed |
| US-6852719-B2 | Dietetics; antidiabetic agents; antiinflammatory agents | PFIZER INC. (US) | 2005-02-08 | — | — | US | disclosed |
| CN-1554680-A | In mold addition polymerization composition of norbornene-type monomers and its crosslinking addition polymer | ס�ѵ�ľ��ʽ���� | 2004-12-15 | — | — | CN | disclosed |
| US-20040014741-A1 | Glucocorticoid receptor modulators | LIU KEVIN K (US) | 2004-01-22 | — | — | US | disclosed |
| US-20020107235-A1 | Glucocorticoid receptor modulators | LIU KEVIN K (US) | 2002-08-08 | — | — | US | disclosed |
| EP-1201649-A1 | Glucocorticoid receptor modulators | Pfizer Products Inc. (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1201660-A1 | Glucocorticoid receptor modulators | Pfizer Products Inc. (US) | 2002-05-02 | — | — | EP | disclosed |
| CN-1333788-A | In-mold addition polymerization of norbornene-type monomers using group 10 metal complexes | GOODRICH CO B F (US) | 2002-01-30 | — | — | CN | disclosed |